Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb 1;13(1):1-45.
doi: 10.5114/aoms.2017.64712. Epub 2016 Dec 19.

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016

Affiliations

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016

Maciej Banach et al. Arch Med Sci. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Prof. Maciej Banach: lectures: Abbott//Mylan, Abbott Vascular, Actavis, Amgen, KRKA, MSD, Sanofi-Aventis; consultations: Abbott Vascular, Amgen, Daichii Sankyo, Esperion, MSD, Resverlogix, Sanofi-Aventis; Prof. Piotr Jankowski: lectures: Amgen, KRKA, MSD, Sanofi-Aventis; consultations: Amgen, MSD, Sanofi-Aventis; Prof. Jacek Jóźwiak: lectures: Valeant, Beoehringer Ingelheim, Śląskie Laboratoria Analityczne; consultations: Valeant, Bayer, Bioton, Beoehringer Ingelheim, Śląskie Laboratoria Analityczne; Prof. Barbara Cybulska: lectures: Amgen, Sanofi, consultations: MSD, Amgen, Sanofi; Prof. Adam Windak: lectures: MSD, Sanofi-Aventis; consultations: MSD, Sanofi Aventis, Polpharma, Merck; Prof. Tomasz Guzik: lectures: Abbott, G-Pharma, Servier (France); Srteering committee/consultations: Novartis, Sanofi-Aventis, Bayer, ALK-Abello; Prof. Artur Mamcarz: lectures: Abbott//Mylan, Actavis, Amgen, Apotex, Astra-Zeneca, Gedeon Richter, MSD, Polpharma, Sandoz, Sanofi-Aventis, Valeant; consultations: MSD, Polpharma, Valeant; Prof. Marlena Broncel: lectures, articles for: MSD, Sanofi, Amgen, Pfizer, Fournier, Bioton, Polpharma; Prof. Tomasz Tomasik: cooperation: Pfizer and Valeant.

Figures

Figure 1
Figure 1
Mean concentrations of lipid profile parameters in LIPIDOGRAM2004 and LIPIDOGRAM2006
Figure 2
Figure 2
SCORE charts calibrated for the Polish population (Pol-SCORE 2015). The numbers in the charts represent the 10-year risk of fatal cardiovascular disease [29]

References

    1. Zdrojewski T, Solnica B, Cybulska B, et al. Prevalence of lipid abnormalities in Poland. The NATPOL 2011 survey. Kardiol Pol. 2016;74:213–23. - PubMed
    1. Rynkiewicz A, Cybulska B, Banach M, et al. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum. J Clin Lipidol. 2013;7:217–21. - PubMed
    1. Colantonio LD, Bittner V, Reynolds K, et al. Association of serum lipids and coronary heart disease in contemporary observational studies. Circulation. 2016;133:256–64. - PMC - PubMed
    1. Banach M, Serban MC. Discussion around statin discontinuation in older adults and patients with wasting diseases. J Cachexia Sarcopenia Muscle. 2016;7:396–9. - PMC - PubMed
    1. Banach M, Rizzo M, Toth P, et al. Statin intolerance – an attempt at a unified definition. Position paper from an International Lipid Expert Panel. Arch Med Sci. 2015;11:1–23. - PMC - PubMed

LinkOut - more resources